Accelerating High Growth Biopharma Scaleups

Transitioning from a successful clinical trial to a commercial product is the most challenging phase for any biopharma company. High Growth Biopharma Scaleups are those that have proven their science and are now focused on aggressive market penetration, manufacturing scale-up, and organizational maturity.

Commercialization Strategy

Funding the launch of new drugs through targeted marketing and sales force expansion.

Phase III Clinical Support

Providing the capital necessary for large-scale pivotal trials to secure regulatory approval.

Market Access & Pricing

Investing in teams that navigate reimbursement negotiations and health technology assessments.

Operational Scaling

Supporting the transition from founder-led management to professional corporate governance.

Accelerating Market Entry

Scaleups require a different set of KPIs than early-stage startups. We focus on customer acquisition costs, market share growth, and the efficiency of the sales pipeline. By leveraging Deal Comparisons, we ensure that our scaleups are valued competitively while maintaining a path to profitability.

Strategic guidance on navigating the ASEAN Harmonized Pharmaceutical Registration.
Facilitating partnerships with global pharma giants for co-marketing agreements.
Funding the expansion of sales teams into emerging markets like Indonesia and Vietnam.
Optimizing pricing strategies to balance accessibility with investor returns.

Our goal is to prepare biopharma scaleups for a successful exit, whether through an IPO on regional exchanges or a strategic acquisition.

Stay updated on the latest success stories in our portfolio by visiting the News section.